文献速递免疫规划

添加非翻译区改进重组禽副黏病毒血清型10载体疫苗

Improvement of a recombinant avian avulavirus serotype 10 vectored vaccine by the addition of untranslated regions.
PubMed 文献 · Vaccine · 2019-11-11

本研究通过在表达高致病性禽流感病毒血凝素基因的重组禽副黏病毒血清型10载体疫苗中引入各基因的5'和3'非翻译区,以增强外源HA蛋白表达。结果显示含非翻译区的重组疫苗接种鸡后对高致病性禽流感病毒攻击提供100%保护,而无非翻译区对照疫苗保护率为70%且50%鸡排毒。结论认为非翻译区可增强外源HA基因表达并提高疫苗效力。

要点

  • 含非翻译区的重组疫苗接种鸡后对高致病性禽流感病毒攻击提供100%保护。
  • 无非翻译区对照疫苗保护率为70%,且50%鸡在喉或泄殖腔拭子排毒。
  • 非翻译区使HA mRNA比例增加1.55-1.84倍,HA蛋白水平增加148-1151倍。

核心结论

  • 禽副黏病毒血清型10的非翻译区能增强外源HA基因表达,从而提高重组载体疫苗的效力,有助于保护全球鸡群免受高致病性禽流感侵害。

研究设计与样本

  • 在重组禽副黏病毒血清型10/HA疫苗中引入各基因的5'和3'非翻译区构建不同rAAv10-UTRs,并以不含非翻译区的rAAv10-nonUTR为对照,用鸡胚和白色来航鸡评估非翻译区对mRNA转录、HA蛋白表达和疫苗效力的影响。

主要发现

  • 感染rAAv10-UTRs的细胞中HA基因mRNA占载体来源mRNA的比例较对照增加1.55-1.84倍,HA蛋白水平较对照增加148-1151倍。
  • 接种rAAv10-UTRs的鸡对高致病性禽流感病毒攻击提供100%保护。
  • 接种rAAv10-NP-UTR、rAAv10-F-UTR或rAAv10-HN-UTR的鸡喉和泄殖腔拭子均未排毒。
  • 接种rAAv10-nonUTR的鸡保护率为70%,攻击后50%的鸡在泄殖腔或喉拭子排毒。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We have previously developed a recombinant avian avulavirus serotype 10 (rAAvV-10/HA) expressing the hemagglutinin (HA) gene of a highly pathogenic avian influenza virus (HPAIV) as an emergency vaccine for poultry. rAAvV-10/HA can overcome the activity of the anti-AAvV-1 (Newcastle disease virus) antibody acquired by commercial chickens upon routine vaccination. Most chickens do not have the anti-AAvV-10 antibody, which could interfere with the vaccine efficacy. However, the vaccine efficacy of rAAvV-10/HA is not satisfactory in chickens even though it affords protection against an HPAIV challenge. In the present study, we improved the rAAvV-10/HA vaccine by enhancing the expression of the exogenous HA protein. METHODS: The 5' and 3' untranslated regions (UTR) of each AAvV-10 gene were flanked with the exogenous HA gene cassette to modify rAAvV-10/HA, yielding different rAAv10-UTRs. As a control, rAAv10-nonUTR that did not contain any UTRs was generated. The effects of UTRs on mRNA transcription, HA protein expression, and vaccine efficacy were then examined using embryonated chicken eggs and white leghorn chickens. RESULTS: The proportion of the HA gene mRNA among the vector-derived mRNAs (1.55-1.84-fold increase vs. the control) and HA protein levels (148-1151-fold increase vs. the control) in cells infected with rAAv10-UTRs were higher than in those infected with rAAv10-nonUTR. In vivo, vaccination of chickens with rAAv10-UTRs resulted in 100% protection against an HPAIV challenge. No chickens vaccinated with rAAv10-NP-UTR, rAAv10-F-UTR, or rAAv10-HN-UTR shed the virus in the throat and cloaca swabs. By contrast, rAAv10-nonUTR vaccination offered 70% protection, with 50% of chickens shedding the virus in the cloaca or throat swabs after the challenge. We conclude that the AAvV-10 UTRs can enhance the expression of the exogenous HA gene, resulting in improved efficacy of the rAAvV-10/HA vector vaccine. This improvement aids in the protection of flocks worldwide from the highly pathogenic avian influenza.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Tsunekuni R, Tanikawa T, Nakaya T, et al. Improvement of a recombinant avian avulavirus serotype 10 vectored vaccine by the addition of untranslated regions. Vaccine. 2019. PMID: 31718900. doi:10.1016/j.vaccine.2019.10.098

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。